Skip Navigation
  Search Menu
Find an Expert


Edward James Tanner, III, M.D.

Photo of Dr. Edward James Tanner, III, M.D.

Associate Director, F.J. Montz Fellowship in Gynecologic Oncology

Associate Professor of Gynecology and Obstetrics


Expertise: Cervical Cancer, Gynecologic Cancers, Gynecologic Oncology, Minimally Invasive Surgery, Ovarian Cancer, Robotic Surgery, Sarcoma, Uterine Cancer, Uterine Fibroids, Vulvar Cancer more

Research Interests: Surgical Management of Advanced Ovarian Cancer; Sentinel Lymph Node Mapping of Endometrial Cancer; Robotic and Minimally Invasive Surgery for Gynecologic Cancers; Fertility Preservation for Cervical and Endometrial Cancer; Management of Uterine Sarcomas more

Request an Appointment

I live in Maryland

Request an appointment through MyChart!

I live outside of Maryland

Request Appointment

I live outside of the United States

Request Appointment


Johns Hopkins Outpatient Center
Appointment Phone: 410-955-8240

601 N. Caroline St.
Baltimore, MD 21287 map
Phone: 410-955-8240

Johns Hopkins Medicine - Green Spring Station
Appointment Phone: 410-955-8240

10755 Falls Road
Pavilion I Suite 420
Lutherville, MD 21093 map
Phone: 410-583-2749


Dr. Edward Tanner is an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and at Johns Hopkins Bayview Medical Center. He serves as the director of surgical innovations and the robotic surgery program in the department, leader of the Kelly Gynecologic Oncology Service’s Sentinel Lymph Node Program, and associate director of the F.J. Montz Fellowship Program in Gynecologic Oncology.

Additionally, Dr. Tanner is co-leader of the GYN/Urology Comprehensive Unit-based Safety Program and the Robotic Surgery Steering Committee. In these roles, he oversees a multidisciplinary program in surgical quality and patient safety at the hospital. Dr. Tanner is recognized for his outstanding surgical skills, compassionate bedside manner and teaching abilities.

Dr. Tanner’s clinical interests include the surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He has a particular focus on developing innovative techniques for robotic surgery in patients with uterine and cervical cancers, including single-site robotic surgery.

His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications in patients undergoing surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has co-authored more than 30 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations in gynecologic cancer.

A native of Baltimore, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was one of the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. more


  • Associate Director, F.J. Montz Fellowship in Gynecologic Oncology
  • Co-Director of Robotic Surgery, Gynecology
  • Associate Professor of Gynecology and Obstetrics



  • MD, University of Alabama at Birmingham (2004)


  • Johns Hopkins University School of Medicine / Obstetrics and Gynecology (2008)


  • Memorial Sloan-Kettering Cancer Center / Gynecologic Oncology (2012)

Board Certifications

  • American Board of Obstetrics and Gynecology / Gynecologic Oncology (2015)
  • American Board of Obstetrics and Gynecology / OB/GYN-General (2013)

Research & Publications

Clinical Trial Keywords

National Cancer Institute, Gynecologic Oncology Group

Selected Publications

View all on Pubmed

Tanner E, Zahurak M, Bristow R, Diaz-Montes T. Outcomes of Younger Patients with Ovarian Cancer. Gynecol Oncol. 2008; 111(2): 221-5. PMID: 18786718.

Tanner E, Chi D, Eisenhauer E, Diaz-Montes T, Santillan A, Bristow R. Early Detection of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Survival Benefit or Lead Time Bias. Gynecol Oncol. 2010; 117(2):336-40. PMID: 20153027.

Pant A, Diaz-Montes T, Tanner E, Ahmad S, Giuntoli R, Holloway R, Bristow R. Correlation of Extreme Drug Resistance Assay Results and Progression Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. J Chemother. 2010; 22(4): 270-4. PMID: 20685633.

Shih K, Qin L-X, Tanner E, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat R, Levine D. A MicroRNA Survival Signature (MiSS) for Advanced Ovarian Cancer. Gynecol Oncol. 2011; 121 (3): 444-50. PMID: 21354599.

Tanner E, Leitao M, Garg K, Chi D, Sonoda Y, Gardner G, Barakat R, Jewell E. The Role of Cytoreductive Surgery for Newly Diagnosed Advanced-Stage Uterine Carcinosarcoma. Gynecol Oncol. 2011; 123 (3): 548-52. PMID: 21945551.

Tanner E, Black D, Zivanovic O, Kehoe S, Dao F, Konner J, Barakat R, Lichtman S, Levine D. Patterns of First Recurrence Following Adjuvant Intraperitoneal Chemotherapy for Stage IIIC Ovarian Cancer. Gynecol Oncol. 2012; 124 (1): 59-62. PMID: 21982046.

Tanner E, Long K, Zhou Q, Brightwell R, Gardner G, Abu-Rustum N, Leitao M, Sonoda Y, Chi D. Impact of Operative Start Time on Surgical Outcomes in Patients Undergoing Primary Cytoreduction for Advanced Ovarian Cancer. Gynecol Oncol. 2012; 126 (1): 58-63. PMID: 22507533.

Hyman D, Long K, Tanner E, Grisham R, Arnold A, Bhatia J, Spriggs D, Soslow R, Kauff N, Levine D. Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma. Gynecol Oncol. 2012; 126 (2): 224-8. PMID: 22579790.

Tanner E, Garg K, Leitao M, Soslow R, Hensley M. High Grade Undifferentiated Uterine Sarcoma: Surgery, Treatment, and Survival Outcomes. Gynecol Oncol. 2012; 127 (1): 27-31. PMID: 22750260.

Tanner E, Long K, Feffer J, Leitao M, Abu-Rustum N, Barakat R, Chi D, Gardner G. Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Gynecol Oncol. 2012; 128 (1): 28-33. PMID: 23017819.

Tanner E, Toussaint T, Leitao M, Hensley M, Soslow R, Gardner G, Jewell E. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol. 2013; 129 (1): 140-4. PMID: 23283300.

Sandadi S, Tanner E, Khoury-Collado F, Kostolias A, Makker V, Chi D, Sonoda Y, Alektiar K, Barakat R, Abu-Rustum N. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Oncol. 2013; 23 (3): 553-8. PMID: 23392402.

Barlin J, Long K, Tanner E, Gardner G, Leitao M, Levine D, Sonoda Y, Abu-Rustum N, Chi D. Optimal (≤1cm) but Visible Residual Disease: Is Extensive Debulking Warranted? Gynecol Oncol. 2013; 130 (2): 284-8. PMID: 23672929.

Ricci S, Giuntoli R, Eisenhauer E, Lopez M, Krill L, Tanner E, Gehrig P, Havrilesky L, Secord A, Levinson K, Frasure H, Celano P, Fader A. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? Gynecol Oncol. 2013; 131 (3): 629-33. PMID: 24016408.

Long K, Tanner E, Frey M, Leitao M, Levine D, Gardner G, Sonoda Y, Abu-Rustum N, Barakat R, Chi D. Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity. Gynecol Oncol. 2013; 131(3): 525-30. PMID: 24016410.

Scheib S, Tanner E, Green I, Fader A. Laparoscopy in the Morbidly Obese: Physiologic Considerations and Surgical Techniques to Optimize Success. J Minim Invasive Gynecol. 2013; 21 (2): 182-95. PMID: 24100146.

Fader A, Java J, Krivak T, Bristow R, Tergas A, Bookman M, Armstrong D, Tanner E, Gershenson D. The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2014; 132(3):560-5. PMID: 24333362.

Sinno A, Fader A, Long K, Giuntoli R, Tanner E. A Comparison of Colorimetric versus Fluorometric Sentinel Lymph Node Mapping During Robotic Surgery for Endometrial Cancer. Gynecol Oncol. 2014; 134 (2): 281-6. PMID: 24882555.

Suidan R, St. Clair C, Lee S, Barlin J, Long Roche K, Tanner E, Sonoda Y, Barakat R, Zivanovic O, Chi D. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecol Oncol. 2014; 134 (3): 468-72. PMID: 25042672.

Cripe J, Tseng J, Eskander R, Fader A, Tanner E, Bristow R. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality. Ann Surg Oncol. 2014; 22(2): 655-61. PMID: 25155402.

Suidan R, Zhou Q, Iasonos A, O'Cearbhaill R, Chi D, Long Roche K, Tanner E, Denesopolis J, Barakat R, Zivanovic O. Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2015; 25(4): 599-606. PMID: 2566443

Sinno A, Fader A, Tanner E. Single Site Robotic Sentinel Lymph Node Biopsy and Hysterectomy in Endometrial Cancer. Gynecol Oncol. 2015; 137(1): 190. PMID: 25684218

Kushnir C, Angarita A, Havrilesky L, Thompson S, Spahlinger D, Sinno A, Tanner E, Secord A, Roche K, Stone R, Fader A. Selective Cardiac Surveillance in Patients with Gynecologic Cancer Undergoing Treatment with Pegylated Liposomal Doxorubicin (PLD). Gynecol Oncol. 2015; 137(3): 503-7. PMID: 25735254.

Tanner E, Sinno A, Stone R, Levinson K, Long K, Fader A. Factors Associated with Successful Bilateral Sentinel Lymph Node Mapping in Endometrial Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26095896.

Sinno A, Tanner E. Robotic Laparoendoscopic Single Site Radical Hysterectomy with Sentinel Lymph Node mapping and Pelvic Lymphadenectomy for Cervical Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26307401.

Cholakian D, Hacker K, Fader A, Gehrig P, Tanner E. Effect of Oral Versus Intrauterine Progestins on Weight in Women Undergoing Fertility Preserving Therapy for Complex Atypical Hyperplasia or Endometrial Cancer. Gynecol Oncol 2015; [epub ahead of print].

Fader A, Weise R, Sinno A, Tanner E, Borah B, Moriarty J, Bristow R, Makary M, Pronovost P, Hutfless S, Dowdy S. Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity. Gynecol Oncol 2015; [epub ahead of print]. PMID: 26646127.

Activities & Honors


  • Excellence in Teaching Award, Johns Hopkins Hospital, 2013
  • Virginia K. Pearce Award for Best Poster, Society of Memorial Gynecologic Oncologists Annual Meeting, 2009
  • Excellence in Teaching Award, Johns Hopkins Hospital, 2008
  • Excellence in Teaching Award, Johns Hopkins Hospital, 2006


  • American Association of Gynecologic Laparoscopy
  • American College of Obstetrics and Gynecology
  • Mid-Atlantic Gynecologic Oncology Society
  • Society of Gynecologic Oncology
  • Society of Memorial Gynecologic Oncologists

Videos & Media

Minimally Invasive Surgery for Gynecologic Cancer Q&A

Associate Professor of Gynecology and Obstetrics, Dr. Edward Tanner, discusses the benefits, risks and recovery of minimally invasive surgery for gynecologic cancers.

Lectures and Presentations

  • Screening for Ovarian Cancer
    Baltimore (01/19/2012)
    Greater Baltimore Medical Center
  • Screening for Ovarian Cancer
    Washington (01/04/2013)
    Sibley Memorial Hospital
  • Screening for Gynecologic Cancers
    Woodbridge (01/03/2013)
    Sentara Northern Virginia Medical Center
  • Screening for Ovarian Cancer
    Washington (01/24/2013)
    Georgetown/Washington Hospital Center
  • Screening for Ovarian Cancer
    Grand Round Lectures, Baltimore, MD (10/19/2012)
    Greater Baltimore Medical Center
  • Screening for Ovarian Cancer
    Grand Round Lectures, Washington, DC (03/04/2013)
    Sibley Memorial Hospital
  • Screening for Gynecologic Cancers
    Grand Round Lectures, Woodbridge, VA (04/03/2013)
    Sentara Northern Virginia Medical Center
  • Screening for Ovarian Cancer
    Grand Round Lectures, Washington, DC (10/24/2013)
    Georgetown/Washington Hospital Center
  • Practical Paradigms for Critical Clinical Challenges in Gynecologic Oncology
    Classification and Current Treatment Strategies for Uterine Sarcomas, Washington, DC (11/03/2012)
    SGO 2012 State of the Art Conference
  • The Skinny on the Mini: Minilaparoscopy, LESS, Robotic Single-Site and the Next Frontier in Alternative Access
    Conventional Laparoscopic Access Techniques: A Review and Critical Appraisal, Washington, DC (11/11/2013)
    AAGL Annual Meeting
  • Introduction of a Sentinel Lymph Node Mapping Program
    Boston, MA (12/05/2013)
    Endometrial Cancer at Johns Hopkins Hospital
  • Fluorometric Imaging for Endometrial Cancer
    Invited Lecture, 2nd Fengxian International Forum of Medical Science and Technology, Shanghai, China (08/30/2014)
  • Sentinel Lymph Node Mapping for Endometrial Cancer
    Invited Speaker, Grand Rounds, Baltimore, MD (02/13/2015)
    University of Maryland Department of OB/GYN
  • Single Port Robotic Surgery
    Invited Speaker, Surgical Innovations Course, Updates and Innovations in Gynecologic Surgery Course, Baltimore, MD (05/29/2015)
    Johns Hopkins Hospital
  • Techniques, Advantages, and Drawbacks of Single-port Surgery
    Invited Lecture, Surgical Innovations Course, Minimally Invasive Therapy Single Incision Laparoscopic Surgery Workshop, Shanghai, China (11/03/2015)
    Asia-Pacific Association for Gynecologic Endoscopy

Recent News Articles and Media Coverage

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments also are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile